The influence of nutritional factors on prostate cancer incidence and aggressiveness

References

• Moradi Sardareh H, Goodarzi MT, Yadegar-Azari R, et al. Prostate cancer antigen 3 gene expression in peripheral blood and urine sediments from prostate cancer and benign prostatic hyperplasia patients versus healthy individuals. J Urol. 2014;11:1952–1958.
   Web of Science ®Google Scholar
• Di Sebastiano KM, Mourtzakis M. The role of dietary fat throughout the prostate cancer trajectory. Nutrients. 2014;6:6095–6109.
   PubMed Web of Science ®Google Scholar
• Patel VH. Nutrition and prostate cancer: an overview. Expert Rev Anticancer Ther. 2014;14:1295–1304.
   PubMed Web of Science ®Google Scholar
• De Nunzio C, Presicce F, Lombardo R, et al. Physical activity as a risk factor for prostate cancer diagnosis: a prospective biopsy cohort analysis. BJU Int. 2016;117:E29–E35.
   PubMed Web of Science ®Google Scholar
• Cuzick J, Thorat MA, Andriole G, et al. Prevention and early detection of prostate cancer. Lancet Oncol. 2014;15:e484–e492.
   PubMed Web of Science ®Google Scholar
• Labbé DP, Zadra G, Ebot EM, et al. Role of diet in prostate cancer: the epigenetic link. Oncogene 2015;34:4683–4691.
   PubMed Web of Science ®Google Scholar
• Canto P, Benitez Granados J, Martinez Ramirez MA, et al. Genetic variants in ATP6 and ND3 mitochondrial genes are not associated with aggressive prostate cancer in Mexican-Mestizo men with overweight or obesity. Aging Male. 2016;19:187–191.
   PubMed Web of Science ®Google Scholar
• Grosman H, Fabre B, Mesch V, et al. Lipoproteins, sex hormones and inflammatory markers in association with prostate cancer [Research Support, Non-U.S. Gov't]. Aging Male. 2010;13:87–92.
   PubMed Web of Science ®Google Scholar
• Singam P, Hong GE, Ho C, et al. Nocturia in patients with benign prostatic hyperplasia: evaluating the significance of ageing, co-morbid illnesses, lifestyle and medical therapy in treatment outcome in real life practice. Aging Male. 2015;18:112–117.
   PubMed Web of Science ®Google Scholar
• Almehmadi Y, Yassin DJ, Yassin AA. Erectile dysfunction is a prognostic indicator of comorbidities in men with late onset hypogonadism. Aging Male. 2015;18:186–194.
   PubMed Web of Science ®Google Scholar
• Yassin DJ, Doros G, Hammerer PG, et al. Long-term testosterone treatment in elderly men with hypogonadism and erectile dysfunction reduces obesity parameters and improves metabolic syndrome and health-related quality of life [Observational Study]. J Sex Med. 2014;11:1567–1576.
   PubMed Web of Science ®Google Scholar
• Yassin A, Nettleship JE, Talib RA, et al. Effects of testosterone replacement therapy withdrawal and re-treatment in hypogonadal elderly men upon obesity, voiding function and prostate safety parameters [Research Support, Non-U.S. Gov't]. Aging Male. 2016;19:64–69.
   PubMed Web of Science ®Google Scholar
• Aragón F, Perdigón G, de Moreno de LeBlanc A. Modification in the diet can induce beneficial effects against breast cancer. World J Clin Oncol. 2014;5:455–464.
   PubMedGoogle Scholar
• Lin PH, Aronson W, Freedland SJ. Nutrition, dietary interventions and prostate cancer: the latest evidence. BMC Med. 2015;13:3.
   PubMed Web of Science ®Google Scholar
• Mandair D, Rossi RE, Pericleous M, et al. Prostate cancer and the influence of dietary factors and supplements: a systematic review. Nutr Metab . 2014;11:30.
   Google Scholar
• Comhaire F, Mahmoud A. Preventing diseases of the prostate in the elderly using hormones and nutriceuticals [Review]. Aging Male. 2004;7:155–169.
   PubMedGoogle Scholar
• Li J, Gu Z, Pan Y, et al. Dietary supplementation of alpha-linolenic acid induced conversion of n-3 LCPUFAs and reduced prostate cancer growth in a mouse model. Lipids Health Dis. 2017;16:136.
   PubMed Web of Science ®Google Scholar
• Masko EM, Allott EH, Freedland SJ. The relationship between nutrition and prostate cancer: is more always better? Eur Urol. 2013;63:810–820.
   PubMed Web of Science ®Google Scholar
• Perez-Cornago A, Travis RC, Appleby PN, et al. Fruit and vegetable intake and prostate cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC). Int J Cancer. 2017;141:287–297.
   PubMed Web of Science ®Google Scholar
• Wu K, Spiegelman D, Hou T, et al. Associations between unprocessed red and processed meat, poultry, seafood and egg intake and the risk of prostate cancer: a pooled analysis of 15 prospective cohort studies. Int J Cancer. 2016;138:2368–2382.
   PubMed Web of Science ®Google Scholar
• Arab L, Su J, Steck SE, et al. Adherence to World Cancer Research Fund/American Institute for Cancer Research lifestyle recommendations reduces prostate cancer aggressiveness among African and Caucasian Americans. Nutr Cancer. 2013;65:633–643.
   PubMed Web of Science ®Google Scholar
• Meng H, Hu W, Chen Z, et al. Fruit and vegetable intake and prostate cancer risk: a meta-analysis. Asia Pac J Clin Oncol. 2014;10:133–140.
   PubMed Web of Science ®Google Scholar
• Fabiani R, Minelli L, Bertarelli G, et al. A Western dietary pattern increases prostate cancer risk: a systematic review and meta-analysis [Meta-Analysis Review]. Nutrients. 2016;8:626.
   PubMed Web of Science ®Google Scholar
• Schwingshackl L, Hoffmann G. Does a Mediterranean-Type Diet Reduce Cancer Risk? [Review]. Curr Nutr Rep. 2016;5:9–17.
   PubMedGoogle Scholar
• Montironi R, Santoni M, Mazzucchelli R, et al. Prostate cancer: from Gleason scoring to prognostic grade grouping. Expert Rev Anticancer Ther. 2016;16:433–440.
   PubMed Web of Science ®Google Scholar
• IBM SPSS Statistics. SPSS predictive analytics software and solutions. [cited 2017 Jun 18]. Available from: http://www-01.ibm.com/software/analytics/spss/2011.
   Google Scholar
• Morote J, Celma A, Planas J, et al. Sedentarism and overweight as risk factors for the detection of prostate cancer and its aggressivenes. Actas Urol Esp. 2014;38:232–237.
   PubMed Web of Science ®Google Scholar
• Hrafnkelsdóttir SM, Torfadóttir JE, Aspelund T, et al. Physical activity from early adulthood and risk of prostate cancer: a 24-Year follow-up study among Icelandic men. Cancer Prev Res. 2015;8:905–911.
   PubMed Web of Science ®Google Scholar
• Grotta A, Bottai M, Adami HO, et al. Physical activity and body mass index as predictors of prostate cancer risk. World J Urol. 2015;33:1495–1502.
   PubMed Web of Science ®Google Scholar
• Liu Y, Hu F, Li D, et al. Does physical activity reduce the risk of prostate cancer? A systematic review and meta-analysis. Eur Urol. 2011;60:1029–1044.
   PubMed Web of Science ®Google Scholar
• De Nunzio C, Albisinni S, Freedland SJ, et al. Abdominal obesity as risk factor for prostate cancer diagnosis and high grade disease: a prospective multicenter Italian cohort study. Urol Oncol. 2013;31:997–1002.
   PubMed Web of Science ®Google Scholar
• Bonn SE, Sjölander A, Tillander A, et al. Body mass index in relation to serum prostate-specific antigen levels and prostate cancer risk. Int J Cancer. 2016;139:50–57.
   PubMed Web of Science ®Google Scholar
• Goktas S, Yilmaz MI, Caglar K, et al. Prostate cancer and adiponectin. Urology. 2005;65:1168–1172.
   PubMed Web of Science ®Google Scholar
• Housa D, Vernerova Z, Heracek J, et al. Adiponectin as a potential marker of prostate cancer progression: studies in organ-confined and locally advanced prostate cancer [Research Support, Non-U.S. Gov't]. Physiol Res. 2008;57:451–458.
   PubMed Web of Science ®Google Scholar
• Ohwaki K, Endo F, Shimbo M, et al. Comorbidities as predictors of incidental prostate cancer after Holmium laser enucleation of the prostate: diabetes and high-risk cancer. Aging Male 2017;23:1–4.
   Web of Science ®Google Scholar
• Vance TM, Wang Y, Su LJ, et al. Sociodemographic, clinical, and lifestyle factors associated with prostate cancer aggressiveness in a population-based study. FASEB J. 2013;27:1061.2–1061.2.
   Web of Science ®Google Scholar
• Goto K, Nagamatsu H, Teishima J, et al. Body mass index as a classifier to predict biochemical recurrence after radical prostatectomy in patients with lower prostate-specific antigen levels. Mol Clin Oncol. 2017;6:748–752.
   PubMedGoogle Scholar
• Cushen SJ, Power DG, Murphy KP, et al. Impact of body composition parameters on clinical outcomes in patients with metastatic castrate-resistant prostate cancer treated with docetaxel. Clin Nutr Espen. 2016;13:e39–e45.
   PubMedGoogle Scholar
• Aune D, De Stefani E, Ronco A, et al. Fruits, vegetables and the risk of cancer: a multisite case-control study in Uruguay. Asian Pac J Cancer Prev. 2009;10:419–428.
   PubMed Web of Science ®Google Scholar
• Askari F, Parizi MK, Jessri M, et al. Fruit and vegetable intake in relation to prostate cancer in Iranian men: a case-control study. Asian Pac J Cancer Prev. 2014;15:5223–5227.
   PubMedGoogle Scholar
• Kobayashi M, Sasaki S, Hamada GS, et al. Serum n-3 fatty acids, fish consumption and cancer mortality in six Japanese populations in Japan and Brazil. Jpn J Cancer Res. 1999;90:914–921.
   PubMedGoogle Scholar
• Chavarro JE, Stampfer MJ, Hall MN, et al. A 22-y prospective study of fish intake in relation to prostate cancer incidence and mortality. Am J Clin Nutr. 2008;88:1297–1303.
   PubMed Web of Science ®Google Scholar
• Szymanski KM, Wheeler DC, Mucci LA. Fish consumption and prostate cancer risk: a review and meta-analysis. Am J Clin Nutr. 2010;92:1223–1233.
   PubMed Web of Science ®Google Scholar
• Spaccarotella KJ, Kris-Etherton PM, Stone WL, et al. The effect of walnut intake on factors related to prostate and vascular health in older men. Nutr J. 2008;7:13.
   PubMed Web of Science ®Google Scholar
• Simon JA, Tanzman JS, Sabaté J. Lack of effect of walnuts on serum levels of prostate specific antigen: a brief report. J Am Coll Nutr. 2007;26:317–320.
   PubMed Web of Science ®Google Scholar
• López-Guarnido O, Alvarez-Cubero MJ, Saiz M, et al. Bioactive compounds of the Mediterranean diet and prostate cancer. J Nutr Health Aging.
   Google Scholar
• Gathirua-Mwangi WG, Zhang J. Dietary factors and risk for advanced prostate cancer. Eur J Cancer Prev. 2014;23:96–109.
   PubMed Web of Science ®Google Scholar